Experimental immune therapy takes on Hard-to-Treat cancers
NCT ID NCT03252938
First seen Jan 23, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This early-stage trial tests an experimental drug called IMP321, which aims to boost the immune system's ability to fight cancer. It is given in new ways, such as direct injection into tumors or into the abdomen, and combined with other cancer treatments. The study includes 83 adults with advanced solid tumors, including lung and bladder cancers, to see if the approach is safe and feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH
Frankfurt, 60431, Germany
-
Helios Dr. Horst Schmidt Klinikum Wiesbaden
Wiesbaden, 65199, Germany
-
Helios Klinikum Bad Saarow
Bad Saarow, 15526, Germany
-
Hämatologisch Onkologische Praxis Eppendorf (HOPE)
Hamburg, 20249, Germany
-
Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim
Cologne, 51109, Germany
-
Krankenhaus Nordwest
Frankfurt, 60488, Germany
-
Marienhospital Herne, Klinik der Ruhr Universität Bochum, Klinik für Urologie
Herne, 44625, Germany
-
Universität Gießen und Marburg GmbH
Giessen, 35392, Germany
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
-
Universitätsklinikum Ulm, Early Clinical Trials Unit (ECTU)
Ulm, 89081, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.